Evidence map›Paper›PMID 18649400›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2008

Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study.

Christopher F McNicoll, Jeanne C Latourelle, Marcy E MacDonald, Mark F Lew, Oksana Suchowersky, Christine Klein, Lawrence I Golbe, Margery H Mark, John H Growdon, G Frederick Wooten and 36 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

46 authors at 20 institutions in 8 countries.

Christopher F McNicollDepartment of Neurology, Boston University School of Medicine, Boston University, Boston, Massachusetts 02118, USA.
Jeanne C Latourelle
Marcy E MacDonald
Mark F Lew
Oksana Suchowersky
Christine Klein
Lawrence I Golbe
Margery H Mark
John H Growdon
G Frederick Wooten
Ray L Watts
Mark Guttman
Brad A Racette
Joel S Perlmutter
Anwar Ahmed
Holly A Shill
Carlos Singer
Marie H Saint-Hilaire
Tiffany Massood
Karen W Huskey
Anita L DeStefano
Tammy Gillis
Jayalakshmi Mysore
Stefano Goldwurm
Gianni Pezzoli
Kenneth B Baker
Ilia Itin
Irene Litvan
Garth Nicholson
Alastair Corbett
Martha Nance
Edward Drasby
Stuart Isaacson
David J Burn
Patrick F Chinnery
Peter P Pramstaller
Jomana Al-Hinti
Anette T Moller
Karen Ostergaard
Scott J Sherman
Richard Roxburgh
Barry Snow
John T Slevin
Franca Cambi
James F Gusella
Richard H Myers
Boston University · USHarvard University · USAarhus University Hospital · DKAuckland City Hospital · NZCleveland Clinic · USIstituti Clinici di Perfezionamento · ITThe University of Sydney · AUUniversity of Kentucky · USWashington University in St. Louis · USBanner Health · USBarrow Neurological Institute · USMaine Medical Center · USMassachusetts General Hospital · USNewcastle Hospitals - Campus for Ageing and Vitality · GBNewcastle University · GBOspedale di Bolzano · ITParkinson's Research and Education Foundation · USPark Nicollet Clinic · USUniversity of Alabama at Birmingham · USUniversity of Arizona · US

Funding

TOXICITY AND SPECIFICITY COMPONENTS OF HD PATHOGENESISP50NS016367 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI GUSELLA, JAMES F · 1996 to 2010
$15.8M
GENETIC LINKAGE STUDY IN PARKINSONS DISEASER01NS036711 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MYERS, RICHARD H · 1997 to 2006
$4.2M
GENETIC MODEL OF HUNTINGTONS DISEASER01NS032765 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MACDONALD, MARCY · 1994 to 2011
$3.7M
NINDS NIH HHS P50 NS016367NINDS NIH HHS P50 NS16367-27NINDS NIH HHS R01 NS032765NINDS NIH HHS R01 NS036711NINDS NIH HHS R01 NS36711-09Telethon GTB07001
6 · The paper itself

Abstract

The ATP/ADP ratio reflects mitochondrial function and has been reported to be influenced by the size of the Huntington disease gene (HD) repeat. Impaired mitochondrial function has long been implicated in the pathogenesis of Parkinson's disease (PD), and therefore, we evaluated the relationship of the HD CAG repeat size to PD onset age in a large sample of familial PD cases. PD affected siblings (n = 495), with known onset ages from 248 families, were genotyped for the HD CAG repeat. Genotyping failed in 11 cases leaving 484 for analysis, including 35 LRRK2 carriers. All cases had HD CAG repeats (range, 15-34) below the clinical range for HD, although 5.2% of the sample (n = 25) had repeats in the intermediate range (the intermediate range lower limit = 27; upper limit = 35 repeats), suggesting that the prevalence of intermediate allele carriers in the general population is significant. No relation between the HD CAG repeat size and the age at onset for PD was found in this sample of familial PD.

Indexed as

Family HealthAdultAgedAged, 80 and overAge of OnsetFemaleGenotypeHumansHuntingtin ProteinHuntington DiseaseMaleMiddle AgedNerve Tissue ProteinsNuclear ProteinsParkinson DiseaseTrinucleotide RepeatsHTT protein, humanHuntingtin ProteinNerve Tissue ProteinsNuclear Proteins

Identifiers

PMID18649400
PMCPMC2655323
OpenAlexW2009562499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.